CJC-1295 (No DAC) / GHRP-2Interpret the evidence
Why food intake is a separate endpoint from growth hormone
2 numbered sourcesSource years 2005, 2024
Peptides consist of short amino-acid chains linked by peptide bonds. Some signal through receptors that affect several processes, including hormone release and eating behavior. CJC-1295 (No DAC) / GHRP-2 describes a pairing of a modified growth hormone–releasing hormone analogue with GHRP-2, also known as pralmorelin. Could a short growth hormone experiment by itself explain what happens to eating behavior? [1, 2]
An older placebo-controlled human study examined GHRP-2 as a single compound in healthy men. Investigators measured how much food participants ate when offered a meal after the experimental exposure. The men ate more during the GHRP-2 condition than during the placebo condition. Growth hormone was measured separately and also increased. The investigators used the comparison to study whether a synthetic peptide could reproduce an aspect of the response associated with ghrelin, a natural hormone involved in feeding. [2]
The two measurements answer different questions. A change in growth hormone describes an endocrine response, while food consumed at a meal describes a behavior during the observation period. An increase in both does not show that one caused the other. A meal experiment can also leave longer-term eating patterns, body weight, and other metabolic outcomes unmeasured. [2]
No recent primary study testing food intake after exposure to the exact catalog pair was identified. The 2005 result concerns GHRP-2 alone in a particular controlled setting. It leaves open whether the addition of the no-DAC analogue would alter meal intake, change the GH response, affect both or affect neither. This distinction is important when an article describes a pairing using only data from one constituent. [1, 2]
Sources
Original works cited in this article. Links open the external record in a new tab.
